Publications by authors named "Emmanuelle Samalin"

Claim this Profile
M
Methodological approach to optimize a step-by-step deterministic linkage of SNDS data with a clinical database (FREGAT) of gastric/gastroesophageal junction adenocarcinoma in France: Pitfalls and learnings.
Magali Laborey, Audrey Lajoinie, Jonatan Freilich, Emmanuelle Samalin, Olivier Bouché

PLoS One· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TFOX versus FOLFOX in first-line treatment of patients with advanced HER2-negative gastric or gastro-oesophageal junction adenocarcinoma (PRODIGE 51- FFCD-GASTFOX): an open-label, multicentre, randomised, phase 3 trial.
Aziz Zaanan, Olivier Bouché, Christelle de la Fouchardière, Karine Le Malicot, Simon Pernot, Emmanuelle Samalin

Lancet Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Triplet chemotherapy plus cetuximab as first-line treatment in extended RAS wild-type metastatic colorectal cancer patients.
Emmanuelle Samalin, Thibault Mazard, Eric Assenat, Magali Rouyer, Christelle de la Fouchardière

Dig Liver Dis· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early palliative care and overall survival in patients with metastatic upper gastrointestinal cancers (EPIC): a multicentre, open-label, randomised controlled phase 3 trial.
Antoine Adenis, Arlette Da Silva, Meher Ben Abdelghani, Vincent Bourgeois, Emilie Bogart, Emmanuelle Samalin

EClinicalMedicine· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atezolizumab plus modified docetaxel, cisplatin, and fluorouracil as first-line treatment for advanced anal cancer (SCARCE C17-02 PRODIGE 60): a randomised, non-comparative, phase 2 study.
Stefano Kim, Francois Ghiringhelli, Christelle de la Fouchardière, Ludovic Evesque, Denis Smith, Emmanuelle Samalin

Lancet Oncol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathogenic alterations in PIK3CA and KMT2C are frequent and independent prognostic factors in anal squamous cell carcinoma treated with salvage abdominoperineal resection.
Abderaouf Hamza, Julien Masliah-Planchon, Cindy Neuzillet, Jérémie H Lefèvre, Magali Svrcek, Emmanuelle Samalin

Int J Cancer· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of gastric adenocarcinoma: A rapidly evolving landscape.
Julien Taieb, Jaafar Bennouna, Frederique Penault-Llorca, Debora Basile, Emmanuelle Samalin

Eur J Cancer· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DCF versus doublet chemotherapy as first-line treatment of advanced squamous anal cell carcinoma: a multicenter propensity score-matching study.
Stefano Kim, Véronique Vendrely, Angélique Saint, Thierry André, Pauline Vaflard, Emmanuelle Samalin

Exp Hematol Oncol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advocacy for colorectal cancer screening and awareness in people with intellectual disability.
Daniel Satgé, Sarah Habib-Hadef, Amaëlle Otandault, Emmanuelle Samalin, Brigitte Trétarre

J Gastrointest Oncol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stereotactic MR-Guided Adaptive Radiotherapy for Pancreatic Tumors: Updated Results of the Montpellier Prospective Registry Study.
Karl Bordeau, Morgan Michalet, Aïcha Keskes, Simon Valdenaire, Pierre Debuire, Emmanuelle Samalin

Cancers (Basel)· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The desmoplastic growth pattern is associated with second-stage completion and longer survival in 2-stage hepatectomy for colorectal cancer liver metastases.
Lakhdar Khellaf, François Quénet, Marta Jarlier, Hugo Gil, Marie-Hélène Pissas, Emmanuelle Samalin

Surgery· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic evaluation of encorafenib with cetuximab in patients with BRAF V600E-mutant metastatic colorectal cancer in France: a cost-effectiveness analysis using data from the BEACON CRC randomised controlled trial.
Jean-Baptiste Trouiller, Bérengère Macabeo, Andrew Poll, Dan Howard, Andy Buckland, Emmanuelle Samalin

BMJ Open· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy in MSI/dMMR tumors in the perioperative setting: The IMHOTEP trial.
Clélia Coutzac, Frederic Bibeau, Meher Ben Abdelghani, Thomas Aparicio, Romain Cohen, Emmanuelle Samalin

Dig Liver Dis· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SOCRATE-PRODIGE 55 trial: A randomized phase II study to evaluate second-line ramucirumab alone or with paclitaxel in older patients with advanced gastric cancer.
Emeric Boisteau, Eric François, Thomas Aparicio, Karine Le Malicot, Rabia Boulahssass, Emmanuelle Samalin

Dig Liver Dis· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Observational Study in a Real-World Setting of Targeted Therapy in the Systemic Treatment of Progressive Unresectable or Metastatic Well-Differentiated Pancreatic Neuroendocrine Tumors (pNETs) in France: OPALINE Study.
Denis Smith, Côme Lepage, Eric Vicaut, Sophie Dominguez, Romain Coriat, Emmanuelle Samalin

Adv Ther· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Value of after Abdominoperineal Resection for Anal Squamous Cell Carcinoma.
Marc Hilmi, Cindy Neuzillet, Jérémie H Lefèvre, Magali Svrcek, Sophie Vacher, Emmanuelle Samalin

Cancers (Basel)· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Second-line treatment after docetaxel, cisplatin and 5-fluorouracil in metastatic squamous cell carcinomas of the anus. Pooled analysis of prospective Epitopes-HPV01 and Epitopes-HPV02 studies.
Morgane Stouvenot, Aurélia Meurisse, Angélique Saint, Bruno Buecher, Thierry André, Emmanuelle Samalin

Eur J Cancer· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perioperative FOLFOX in Patients With Locally Advanced Oesogastric Adenocarcinoma.
Stanislas Quesada, Emmanuelle Samalin, Simon Thezenas, Lakhdar Khellaf, Anne Mourregot

Anticancer Res· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD44v6 Defines a New Population of Circulating Tumor Cells Not Expressing EpCAM.
Guillaume Belthier, Zeinab Homayed, Fanny Grillet, Christophe Duperray, Julie Vendrell, Emmanuelle Samalin

Cancers (Basel)· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Activity of Crizotinib in Chemo-Refractory MET-Amplified Esophageal and Gastric Adenocarcinomas: Results from the AcSé-Crizotinib Program.
Thomas Aparicio, Nathalie Cozic, Christelle de la Fouchardière, Emeline Meriaux, Jérome Plaza, Emmanuelle Samalin

Target Oncol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of the IDEA Collaboration Study Results on Clinical Practice in France for Patients With Stage III Colon Cancer: A National GERCOR - PRODIGE Survey.
Kaïssa Ouali, Anthony Turpin, Cindy Neuzillet, Benoît Rousseau, Marie-Line Garcia-Larnicol, Emmanuelle Samalin

Clin Colorectal Cancer· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FTO-mediated cytoplasmic mA demethylation adjusts stem-like properties in colorectal cancer cell.
Sébastien Relier, Julie Ripoll, Hélène Guillorit, Amandine Amalric, Cyrinne Achour, Emmanuelle Samalin

Nat Commun· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study evaluating the association of gemcitabine, trastuzumab and erlotinib as first-line treatment in patients with metastatic pancreatic adenocarcinoma (GATE 1).
Eric Assenat, Laurent Mineur, Caroline Mollevi, Evelyne Lopez-Crapez, Catherine Lombard-Bohas, Emmanuelle Samalin

Int J Cancer· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pooled analysis of 115 patients from updated data of Epitopes-HPV01 and Epitopes-HPV02 studies in first-line advanced anal squamous cell carcinoma.
Stefano Kim, Aurélia Meurisse, Laurie Spehner, Morgane Stouvenot, Eric François, Emmanuelle Samalin

Ther Adv Med Oncol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[New drug approval: Encorafenib-metastatic colorectal cancers with BRAF V600E mutation after systemic chemotherapy].
Alice Boilève, Emmanuelle Samalin

Bull Cancer· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis